Postoperative nausea and vomiting (PONV) is still an important and common problem. Despite the introduction of new antiemetic drugs, the management of PONV remains difficult. In this article we describe the development and evaluation of a management protocol for PONV, which consists of a treatment algorithm accompanied by a nursing education program. Implementation of this management protocol has been well-accepted by staff, appears to have reduced delay in patient treatment and improved patient care, and has significantly reduced staff workload.
Good management of postoperative nausea and vomiting (PONV) is an important component of postoperative care and may have a significant impact on patient satisfaction 1 , post-surgical morbidity 2 , and the economics of surgical health care 3 . Many patients express special concern about PONV, and some would prefer to avoid it at the expense of increased pain 1, 4 . Severe or protracted retching and vomiting may disrupt surgical incisions and anastomoses, lead to dehydration and electrolyte disturbance, and interfere with postoperative rehabilitation 2 . In the day surgery setting, PONV is a leading anaestheticrelated cause of delayed discharge, and overnight admission to hospital 5 .
Several journals have recently highlighted these issues [6] [7] [8] . Awareness has been further raised by the development and introduction of new antiemetic drugs, particularly the 5-hydroxytryptamine 3 receptor antagonists 9, 10 . Despite pharmacological advances and the widespread use of prophylactic therapy, PONV remains extremely common in some surgical populations. Gynaecological patients have the highest incidence of emetic sequelae 11 and after day-case laparoscopy the incidence of PONV can be as high as 56 to 92% 12, 13 . The use of prophylactic antiemetics reduces this by only 50% 12, 13 . Those having major abdominal gynaecological surgery report PONV, within the first 24 hours of surgery, in 75 to 93% of cases 13, 14 , and drugs such as droperidol or ondansetron reduce the incidence by only 25% 14, 15 .
Given that at least four major neurotransmitter systems are implicated in the aetiology of PONV, it is not surprising that current antiemetic therapy fails to effectively control PONV in high-risk groups. The relevance of surgical and anaesthetic technique is now also receiving attention 16, 17 ; and, if acute postoperative pain management is taken as a model, education, training and improved organizational and implementation structures may prove to be therapeutic strategies of equal or greater importance. There do not appear to be any studies describing the use of effective implementation control systems for PONV 18 .
This paper describes the development and assessment of a postoperative nausea and vomiting management protocol in a tertiary women's hospital over a three-year period, between 1994 and 1997. The goal of this program was to develop treatment algorithms and change nursing protocol in order to establish a rational, pharmacologically sound and cost-effective approach to the management of PONV 19 . It was hoped that delays in patient treatment could be reduced, treatment effectiveness optimized and the workload of nursing, anaesthetic and junior surgical staff reduced.
Development of the PONV protocol
In 1994 it was standard practice for the anaesthetist to prescribe a single antiemetic, usually intramuscularly, to treat PONV in both day surgery patients and inpatients. Subsequent changes to prescription dose or frequency, or alternative orders, were made by both anaesthetic and gynaecological staff, usually at the request of nursing staff. A ward nurse suggested it would be more efficient and effective to prescribe a range of alternative antiemetics for patients who continued to have emetic symptoms or failed to respond to initial therapy. The concept of a treatment algorithm was mooted and a draft algorithm prepared in late 1994 by the Department of Anaesthesia. Following consultation with the Departments of Nursing and Pharmacy, a nursing education program was instituted, and protocols altered to allow accredited nurses to administer appropriate drugs intravenously. Because the above program was implemented initially on a limited basis, and because of the more immediate impact of prolonged PONV on day-care anaesthesia patients, one algorithm was developed for the Day-Surgery and High Dependency Units, and another for the inpatient wards. The attending anaesthetist in the operating room was asked to attach a patient identification label to a protocol form; assign their name, signature and the date; document antiemetics administered intraoperatively; and draw the attention of the recovery room and ward staff to the use of the protocol.
Subsequent modifications to the algorithms (and protocol forms) were made in December 1995 and July 1996, following pilot trials, feedback from nursing staff, more formal assessment of the protocol (vide infra) and extension of the education and training program to inpatient areas. Education has been identified as a factor amenable to improvement in the management of PONV 18 . Our education program was designed to provide basic pharmacological information about the antiemetics included in the algorithms, with the principal aim of improving nursing knowledge of their efficacy, pharmacokinetics and sideeffects.
The treatment algorithms were designed to remind nursing staff of basic principles with respect to the management of PONV (for example, the treatment of pain and the maintenance of adequate hydration); to provide first-and second-line pharmacological treatment options (with a time-frame), according to the antiemetic already administered intra-or postoperatively; and finally to provide instructions as to further management if PONV persisted. Provision was also made on the reverse side of the protocol form for the recording of drugs administered and response to treatment.
Assessment of the PONV protocol
Approximately one year after introduction of the treatment algorithms, in mid-1996, the Department of Pharmacy conducted an audit and patient survey to assess the use, efficacy and acceptance of the algorithms. Fifty PONV protocol sheets were audited for compliance. The algorithm had not been followed correctly in nine cases. Four patients had been administered the wrong antiemetic and in five, adherence to the suggested time-frame for doseintervals had been disregarded.
Questionnaires were distributed to 50 ward nursing staff and 47 (94%) were returned. The responses to questions about the protocols were generally very favourable (Table 1) , supporting their continued use. Thirty questionnaires were distributed to medical staff, both anaesthetic and gynaecological, and 17 (57%) returned ( Table 2) .
Twenty-six per cent of nursing respondents commented that they had found it difficult to determine the designated sequence of drugs, and the results of the compliance audit probably reflect this confusion. The protocol form was subsequently amended to clarify drug selection. It was also altered to reduce the dosage interval between repeat antiemetic doses from six to four hours, because of poor compliance with six hour restriction identified by the form audit. A teaching video was produced to assist education and improve instruction as to the correct use of the algorithms.
In late 1996, a survey of patients, identified from the operating theatre register, was performed on a cohort of 97 patients who had undergone major abdominal or vaginal gynaecological procedures. Seven patients were discharged prior to interview and one spoke no English, leaving 89 completed data sets. Of these, 72 (81%) had been allocated to the PONV protocol form and in 58 cases (81%) compliance with the protocol had been achieved. The results were compared with a historical cohort of 106 patients who had undergone similar surgery in late 1994, before the introduction of the protocol. The records of six patients were unobtainable and a further 18 were excluded from review as they had received droperidol as part of their patient-controlled intravenous analgesic solution postoperatively. Thus, the records of 82 historical control patients were reviewed.
Comparing the current cohort receiving a PONV protocol with the historical cohort during the first three postoperative days, antiemetics used were prochlorperazine, droperidol, metoclopramide, ondansetron and promethazine. Prochlorperazine was the most commonly administered drug in both cohorts, although it represented a smaller proportion of total drug doses given in the PONV group (P= 0.05, chi-squared analysis). The total number of doses of antiemetic was similar (P=0.12, t-test using empirical standard error estimates), although comparing the entire current cohort (PONV protocol n=72 and conventional single-dose prescription n=17) with the historical cohort (n=82), fewer doses were used (mean 2.5 vs 1.8, P<0.04). The number of patients to whom an anaesthetist was called to adjust therapy was one in the PONV protocol group versus 23 in the historical cohort (P<0.0001, Fisher's exact test). Among the current cohort surveyed, the visual analog satisfaction scores (0-100 mm) of those allocated to the protocol, compared to those who were not, were not significantly different (mean 42 vs 33, P=0.25, t-test).
Future Developments
Both anaesthetists and surgeons recognize that there is room for improvement in PONV management, in areas such as new antiemetic drugs, less emetogenic anaesthetic and surgical techniques, and better training and organization 18 . It appears rational to target initially those surgical populations with a high incidence of PONV, or those in whom the early and effective treatment of PONV is important for good postoperative outcome and minimization of hospital stay. After more than two years of use, our PONV protocol continues to be used for the majority of patients having either major gynaecological surgery, or day surgery with high emetogenic potential (e.g. gynaecological laparoscopy). It is hoped further continuous quality improvement activities will lead to improved documentation, especially of nausea scores and episodes of vomiting, and improved algorithm compliance. A formal pharmaco-economic evaluation of the protocol, compared to ad hoc management, would help establish the cost-effectiveness of this approach in monetary terms 19 . Following the extension of our nursing education program to all gynaecological wards, the two treatment algorithms, for inpatients and for daycare anaesthesia patients, are now being amalgamated to produce a single algorithm suitable for both patient populations (Appendix).
We believe our experience provides support for the concept that the development of institution-specific protocols, with accompanying education and training, is worthwhile in terms of reduction of staff workload, better utilization of resources and improved patient care.
